Nuveen, LLC Sera Prognostics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 37,417 shares of SERA stock, worth $110,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,417Holding current value
$110,754% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SERA
# of Institutions
78Shares Held
20.4MCall Options Held
28.9KPut Options Held
36.8K-
Baker Bros. Advisors LP New York, NY5.43MShares$16.1 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$8.98 Million0.43% of portfolio
-
Interwest Venture Management CO2.42MShares$7.15 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$4.89 Million1.65% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$4.17 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $87.6M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...